Earnings Call · Q1 FY2023·2023-05-06

Q1 23EPS +13.96%·Rev n/aQ4 22EPS -19.89%·Rev n/aQ3 22EPS +15.84%·Rev n/aQ2 22EPS +2.62%·Rev n/a⚠ consensus missing

Karyopharm Therapeutics Inc. KPTI

Elhan Webb — Chief Executive Officer

Richard Paulson — President and Chief Operating Officer

Sohanya Cheng — Commercial Leader / Head of Commercial Operations

Reshma Rangwala — Chief Medical Officer

Michael Mason — Chief Financial Officer

+10.2%1d on move date+9.9% vs SPY3d+6.9%5d−4.2%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KPTI calls or request research access.

More KPTI calls Browse calls Request research access